ArticleCancer biology & therapy2019
TLK2 enhances aggressive phenotypes of glioblastoma cells through the activation of SRC signaling pathway.
Muhui Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it